Back to dashboard
MedicaidCoverageLow impact

September 2022 DUR Board Newsletter pdf

Connecticut Medicaid (HUSKY Health)·CT · Endocrinology, Family Medicine, Internal Medicine +1 more·Provider Bulletin
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Connecticut Medical Assistance Program has issued guidelines for gender-affirming hormone therapy coverage, detailing specific medications, dosing protocols, and monitoring requirements for transgender patients. This educational bulletin provides clinical guidance for providers treating transgender patients with hormone therapy but does not specify billing code changes or coverage requirements.

Action Required

Action needed
Review clinical guidelines for gender-affirming hormone therapy to ensure proper documentation and medical necessity requirements are met when billing for hormone treatments in transgender patients. Ensure providers are familiar with recommended monitoring schedules and medication protocols outlined in the Connecticut Medicaid bulletin.